Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

A year ago today the stock price was $5.05. Today the stock price is $4.30. With the exception of a few weeks before and after probuphine approval time in May, TTNP seems to be trading in tandem with BDSI, who produce a "me too" sublingual film in competition with Indivior.

On the other hand, Indivior's price has increased 61% from a year ago, which is puzzling because the market share for suboxone is decreasing. Presumably the market believes only big pharma will benefit from reaction to the opioid epidemic.

Management can't control the stock price, but I do look to them to control the things they can. Such as execution...the IND for ropinirole for example. And providing some meaningful support in the form of candidly updating stockholders of ongoing sales efforts.

And it would be really, really, really nice to hear Rubin or Sunil say they think the stock is undervalued.